Pharmacists in Braintree, Massachusetts


30 Pharmacists found in Braintree
female pharmacist

Kacy Bozoian, RPH


Pharmacist
11 Pearl St, Braintree, MA 02184
781-356-3337    

female pharmacist

Ms. Lian Li, RPH


Pharmacist
316 Grove St, Braintree, MA 02184
781-356-8596     781-325-2163

female pharmacist

Loucine Salloum, RPH


Pharmacist
614 Pond St Unit 1309, Braintree, MA 02184
617-949-6660    



male pharmacist

Nojan Nasseri Niaki


Pharmacist
11 Pearl St, Braintree, MA 02184
781-356-3337    

female pharmacist

Dr. Paige Taylor Rowell, PHARMD


Pharmacist
884 Washington St, Braintree, MA 02184
781-843-0648     781-380-8127

male pharmacist

Mr. Paul Brian Cook, RPH


Pharmacist
316 Grove St, Braintree, MA 02184
781-356-8596    

male pharmacist

Riley S Raiche


Pharmacist
250 Granite St, Braintree, MA 02184
781-817-8810    

male pharmacist

Robert Stone


Pharmacist
185 Campanelli Dr, Braintree, MA 02184
781-380-5609    

female pharmacist

Sabrina Zhou


Pharmacist
270 Grove St, Braintree, MA 02184
781-356-0714    

female pharmacist

Sadaf S Abidi


Pharmacist
250 Granite St, Braintree, MA 02184
781-817-8810    

female pharmacist

Shivani Amin


Pharmacist
270 Grove St, Braintree, MA 02184
781-356-0714     781-848-1491

male pharmacist

Victor M Silva, RPH,PHARMD


Pharmacist
11 Pearl St, Braintree, MA 02184
781-356-3337    

female pharmacist

Vivian Le, DOCTOR OF PHARMACY


Pharmacist
178 Washington St, Braintree, MA 02184
781-843-0731     781-843-1675

female pharmacist

Ying Lam


Pharmacist
178 Washington St, Braintree, MA 02184
781-843-0731    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.